Ethnic Differences in Association of Outcomes with Trimethylamine N-Oxide in Acute Heart Failure Patients
Authors:
Open Access
- 29 June 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 7 (5) , 2373-2378
Abstract
Aims The aim of this study was to investigate whether ethnicity influences the associations between trimethylamine N‐oxide (TMAO) levels and heart failure (HF) outcomes. Methods and results Trimethylamine N‐oxide levels were measured in two cohorts with acute HF at two sites. The UK Leicester cohort consisted mainly of Caucasian (n = 842, 77%) and South Asian (n = 129, 12%) patients, whereas patients in the Japanese cohort (n = 116, 11%) were all Japanese. The primary endpoint was the measurement of all‐cause mortality and/or HF rehospitalization within 1 year post‐admission. Association of TMAO levels with outcome was compared in the entire population and between ethnic groups after adjustment for clinical parameters. TMAO levels were significantly higher in Japanese patients [median (interquartile range): 9.9 μM (5.2–22.8)] than in Caucasian [5.9 μM (3.6–10.8)] and South Asian [4.5 μM (3.1–8.4)] (P < 0.001) patients. There were no differences in the rate of mortality and/or HF rehospitalization between the ethnic groups (P = 0.096). Overall, higher TMAO levels showed associations with mortality and/or rehospitalization after adjustment for confounders ( P = 0.002). Despite no differences between ethnicity and association with mortality/HF after adjustment (P = 0.311), only in Caucasian patients were TMAO levels able to stratify for a mortality/HF event (P < 0.001). Conclusions Differences were observed in the association of mortality and/or rehospitalization based on circulating TMAO levels. Elevated TMAO levels in Caucasian patients showed increased association with adverse outcomes, but not in non‐Caucasian patients.Keywords
Funding Information
- Grants-in-Aid for Scientific Research in Priority Areas (16H05115)
- Japan Agency for Medical Research and Development (17ek0210011h0005)
- Japan Agency for Medical Research and Development (17ek0210011h0005)
This publication has 14 references indexed in Scilit:
- Combined use of trimethylamine N-oxide with BNP for risk stratification in heart failure with preserved ejection fraction: findings from the DIAMONDHFpEF studyEuropean Journal of Preventive Cardiology, 2020
- The Gut Axis Involvement in Heart FailureHeart Failure Clinics, 2020
- Geographical Location Affects the Levels and Association of Trimethylamine N-Oxide with Heart Failure Mortality in BIOSTAT-CHF: A Post-Hoc AnalysisEuropean Journal of Heart Failure, 2019
- Impact of acute choline loading on circulating trimethylamine N-oxide levelsEuropean Journal of Preventive Cardiology, 2019
- Association with Outcomes and Response to Treatment of Trimethylamine N-Oxide in Heart Failure: Results from BIOSTAT-CHFEuropean Journal of Heart Failure, 2018
- Trimethylamine-N-oxide and Heart Failure With Reduced Versus Preserved Ejection FractionJACC, 2017
- Trimethylamine‐N‐oxide (TMAO) response to animal source foods varies among healthy young men and is influenced by their gut microbiota composition: A randomized controlled trialMolecular Nutrition & Food Research, 2016
- Trimethylamine N-oxide and prognosis in acute heart failureHeart, 2016
- Microbiota‐dependent metabolite trimethylamine‐N‐oxide is associated with disease severity and survival of patients with chronic heart failureJournal of Internal Medicine, 2014
- Prognostic Value of Elevated Levels of Intestinal Microbe-Generated Metabolite Trimethylamine-N-Oxide in Patients With Heart FailureJACC, 2014